摘要
冠状动脉支架术是心血管病治疗学上的一次革命,但3~6个月后再狭窄率大约为30%左右,严重危及人们的生命健康。因此,再狭窄的防治已成为心血管病研究的一个重要课题。本文对涂层支架对再狭窄的防治做一综述。
出处
《国外医学(老年医学分册)》
2003年第2期49-53,共5页
Foreign Medical Sciences(Geriatrics)
参考文献24
-
1Topol EJ,P Serruys PW.Frontiers in interventional cardiology.Circulation,1998;98:1802~1820
-
2Guzman LA,Labhasetwar V,Song C et al.Local Intraluminal Infusion of Biodegradable Polymeric Nanoparticles.A Novel Approach for Prolonged Drug Delivery After Balloon Angioplasty.Circulation,1996;94:1441~1448
-
3Galli M,Sommariva L,Prati F et al.Acute and mid-term results of phosphorylcholine-coated stents in primary coconary stenting for acute myocardial infraction.Catheter Cardiaovasc Interv,2001;53:182~187
-
4Whelan DM,van der Giessen WJ,Krabbendam SC et al.Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries.Heart,2000;83:338~345
-
5Verheye S,Markou CP.Salam MY et al.Reduced Thrombus Formation by Hyaluronic Acid Coating of Endovascular Devices.Arteriosclerosis Thrombosis and Vascular Biology,2000;20:1168
-
6Alt E,Haehnel I,Beilharz C et al.Inhibition of neointima formation after experimental coronary artery stenting.Corculation2000;101:1553
-
7Vrolix MCM,Legrand VM,Reiber JHC et al.Heparin-coated wiktor stents in human coronary arteries(mentor trail).Am J Cardiol,2000;86:385~389
-
8Shin EK,Son JW,Sohn MS et al.Efficacy of heparin-coated stent in early setting of acute myocardial infraction.Catheter Cardiovasc Interv,2001;52:306~312
-
9Serruys PW,Emanuelsson H,van der Giessen W et al.Heparin-coated Palmaz-Schatz stents in human coronary arteries.early outcome of the benestent-Ⅱ pilot study.Circulation,1996;93:412~422
-
10Vrolix MCM,Legrand VM,Reiber JHC et al.Heparin-coated wiktor stents in human coronary arteries(mentor trail).Am J Cardiol,2000;86:385~389
同被引文献21
-
1Nikol S, Hofling B. Regulation of smooth muscle cell proliferation and its possible role in preventiong restenosis postangioplasty [J]. Wien Klin Wochenschr, 1995, 107(13): 379-382.
-
2Farb A, Heller PF, Shroff S, et al. Pathological analysis of local delivery of paclitaxel via a polymercoated stent [J].Circulation,2001, 104: 473-479.
-
3Galli M, Sommariva L, Prati F, et al. Acute and mid-term results of phosphorylcholine-coated stents in primary coronary stenting for actue myocardial infraction [ J ]. Catheter Cardiovasc Interv, 2001, 53:182-187.
-
4Rousseau H. Self-expanding endocascular sternt in experimental atherosclerosis: Work in progress [ J ].Radiolgoy,1989, 170: 773.
-
5kuhn FP. Renal artery stenosis: preliminary results of treatment with the strecker stent [J]. Radiology, 1991, 180(2): 367-370.
-
6Zider JP. Short and long-term vascuiar tissoe response in the Duke bioabsorbable stent [J] . JACC, 1993, 21 (suppl):439A.
-
7Suswa T. Biodegradable intracoronary stent in adult dogs [J].JACC, 1993, 21 (suppl): 484A.
-
8Shin KE, Son JW, Sohn MS, et al. Efficacy of heparincoated sent in early setting of acute myocardial infraction [J]. Catheter Cardiovasc Interv, 2001, 52: 306-312.
-
9Matsumoto Y, Shimokawa H, Morishige K, et al.Biodegradable intracoronary stent in adult dogs [ J ].Cardiovasc Pharmacoi, 2002, 39 (4): 513-522.
-
10Alt E, Haehnel I, Beilharz C, et al. Inhibition of neointima formation after experimental coronary artery stenting: a new biodegradable stentcoating releasing hirudin and the prostacyclin analogue iloprost [ J ]. Circulation, 2000, 101(12) : 1453-1458.
二级引证文献7
-
1王晓瑜.药物支架不良事件分析研究[J].上海食品药品监管情报研究,2009(1):42-45.
-
2胡延春,钱久光.药物洗脱支架与裸支架置入治疗冠心病的安全性及生物相容性比较[J].中国组织工程研究与临床康复,2008,12(13):2515-2518. 被引量:5
-
3王晓瑜,杜文民,王宏敏,金慧琳,徐建龙,王彤春,郑洪臻.西罗莫司在药物洗脱支架中的应用[J].世界临床药物,2009,30(1):52-55. 被引量:1
-
4李乐雯,张艳,习隽丽,王家昆,贝筝,吴瑞.药物洗脱支架与金属支架生物相容性比较及支架置入后的血管再狭窄[J].中国组织工程研究与临床康复,2009,13(26):5125-5128.
-
5赵惠,肖虹.冠状动脉药物洗脱支架的特点及其临床安全性[J].中国组织工程研究与临床康复,2009,13(38):7575-7578. 被引量:4
-
6张成举.国产爱克塞尔支架与进口西罗莫可支架疗效比较[J].中国医学创新,2011,8(1):53-54.
-
7罗先润,曹程浩,魏娜,张辉,娄云霄,李朝辉,牛颖.金属裸支架在老年冠心病患者中的应用[J].中国心血管病研究,2012,10(12):908-910.
-
1郭瑞光,王喆琨,苗积国.冠状动脉支架内再狭窄的研究进展[J].中国当代医药,2013,20(23):29-31. 被引量:9
-
2吴鹏,姜大春,秦鈺萍,尹刚,虞慎也,石国芹.高原冠心病患者冠状动脉支架内再狭窄的危险因素分析[J].西南国防医药,2012,22(4):410-411. 被引量:12
-
3张春吉.益心舒胶囊治疗糖尿病伴冠状动脉支架术后心绞痛的疗效观察[J].中西医结合心血管病电子杂志,2015,3(23):95-96. 被引量:1
-
4孙炎华,张高星,林如明,赖兆新,谭文锋,彭宇程,任强,赖浚兴,宋岸坚.冠状动脉支架术后医生电话随访对患者依从性的影响[J].岭南心血管病杂志,2013,19(4):421-423. 被引量:6
-
5方中,孙一康,高敏,喻卓.不稳定型心绞痛合并糖尿病患者经皮冠状动脉介入术后应用国产氯吡格雷的疗效观察[J].昆明医学院学报,2010,31(2):57-60. 被引量:5
-
6陈敏.冠心Ⅲ号治疗冠状动脉术后心绞痛48例[J].中国中医急症,2010,19(10):1771-1772. 被引量:1
-
7刘洋.不要让冠心病在沉默中“爆发”——知名心血管专家谈冠心病的治疗[J].健康大视野,2008(4):66-69.
-
8钱惠东,吴翔.PTCA及植入支架对冠心病患者QT离散度的影响[J].南通医学院学报,2000,20(2):186-186.
-
9林捷,张怀勤,黄伟剑,范良好,赵玉香.冠状动脉内支架的临床应用价值[J].温州医学院学报,1998,28(1):37-38.
-
10Petty TL,王道宏,高方彤.家庭氧疗是晚期COPD治疗的革命[J].国外医学(呼吸系统分册),1991,11(3):144-146. 被引量:3